The emerging treatment of the medication represents a significant breakthrough in the handling of the condition. Unlike existing therapies, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide059110.daneblogger.com/40649028/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment